title: Memantine and catatonic schizophrenia.
authors.forename: Christopher
authors.initials: C
authors.lastname: Thomas
authors.forename: Brendan T
authors.initials: BT
authors.lastname: Carroll
authors.forename: Robert T
authors.initials: RT
authors.lastname: Maley
authors.forename: Kameshwari
authors.initials: K
authors.lastname: Jayanti
authors.forename: Atchuthamba
authors.initials: A
authors.lastname: Koduri
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008559:Memantine / Q000627:therapeutic use*; D008875:Middle Aged; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D012560:Schizophrenia, Catatonic / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D003024:Clozapine; D008559:Memantine